Sandbox: TAVI - AUC: Difference between revisions
Arzu Kalayci (talk | contribs) |
Arzu Kalayci (talk | contribs) |
||
Line 164: | Line 164: | ||
| '''Preserved Ejection Fraction (≥50%)''' || || || | | '''Preserved Ejection Fraction (≥50%)''' || || || | ||
|- | |- | ||
| - AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) - Vmax ≥4 m/sec or mean gradient ≥40 mmHg on resting echo - Symptomatic - High or intermediate surgical risk | | - AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) | ||
- Vmax ≥4 m/sec or mean gradient ≥40 mmHg on resting echo - Symptomatic | |||
- High or intermediate surgical risk | |||
| bgcolor="LightCoral" | R (1) || bgcolor="LightCoral" | R (2) || bgcolor="LightGreen" | A (9) | |||
|- | |- | ||
| - AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) - Vmax ≥4 m/sec or mean gradient ≥40 mmHg on resting echo - Symptomatic - Low surgical risk | | - AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) | ||
- Vmax ≥4 m/sec or mean gradient ≥40 mmHg on resting echo - Symptomatic | |||
- Low surgical risk | |||
| bgcolor="LightCoral" | R (1) || bgcolor="LightCoral" | R (1) || bgcolor="LightGreen" | A (9) | |||
|- | |- | ||
| - AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) - Low flow - Low gradient - Symptomatic - Evidence of a severely calcified valve - Clinical, hemodynamic, and anatomic data support valve obstruction as the most likely cause of symptoms - High or intermediate surgical risk | | - AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) | ||
- Low flow - Low gradient - Symptomatic | |||
- Evidence of a severely calcified valve - Clinical, hemodynamic, and anatomic data support valve obstruction as the most likely cause of symptoms | |||
- High or intermediate surgical risk | |||
| bgcolor="LightCoral" | R (2) || bgcolor="LightCoral" | R (3) || bgcolor="LightGreen" | A (8) | |||
|- | |- | ||
| - AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) - Low flow - Low gradient - Symptomatic - Evidence of a severely calcified valve - Clinical, hemodynamic, and anatomic data support valve obstruction as the most likely cause of symptoms - Low surgical risk | | - AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) | ||
- Low flow - Low gradient | |||
- Symptomatic - Evidence of a severely calcified valve | |||
- Clinical, hemodynamic, and anatomic data support valve obstruction as the most likely cause of symptoms - Low surgical risk | |||
| bgcolor="LightCoral" | R (1) || bgcolor="LightCoral" | R (1) || bgcolor="LightGreen" | A (9) | |||
|- | |- | ||
| - AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) - Low flow - Low gradient - Evidence of a severely calcified valve - Asymptomatic - High or intermediate surgical risk | | - AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) | ||
- Low flow - Low gradient | |||
- Evidence of a severely calcified valve - Asymptomatic | |||
- High or intermediate surgical risk | |||
| bgcolor="LemonChiffon" | M (6) || bgcolor="LightCoral" | R (3) || bgcolor="LemonChiffon" | M (4) | |||
|- | |- | ||
| - AVA ≤1.0 cm2 (and indexed AVA ≤0.6 cm2/m2) - Low gradient - Low flow - Evidence of a severely calcified valve - Asymptomatic - Low surgical risk | | - AVA ≤1.0 cm2 (and indexed AVA ≤0.6 cm2/m2) | ||
- Low gradient - Low flow | |||
- Evidence of a severely calcified valve - Asymptomatic | |||
- Low surgical risk | |||
| bgcolor="LemonChiffon" | M (6) || bgcolor="LightCoral" | R (2) || bgcolor="LemonChiffon" | M (4) | |||
|- | |- | ||
| - AVA ≤1.0 cm2 (and indexed AVA ≤0.6 cm2/m2) - Normal flow - Low gradient - Confirmation of internal consistency of the AVA, flow, and gradient measurements - Evidence of a severely calcified valve - Symptoms believed to be due to AS - High or intermediate surgical risk | | - AVA ≤1.0 cm2 (and indexed AVA ≤0.6 cm2/m2) | ||
- Normal flow - Low gradient | |||
- Confirmation of internal consistency of the AVA, flow, and gradient measurements - Evidence of a severely calcified valve | |||
- Symptoms believed to be due to AS - High or intermediate surgical risk | |||
| bgcolor="LightCoral" | R (3) || bgcolor="LemonChiffon" | M (4) || bgcolor="LightGreen" | A (7) | |||
|- | |- | ||
| - AVA ≤1.0 cm2 (and indexed AVA ≤0.6 cm2/m2) - Normal flow - Low gradient - Confirmation of internal consistency of the AVA, flow, and gradient measurements - Evidence of a severely calcified valve - Symptoms believed to be due to AS - Low surgical risk | | - AVA ≤1.0 cm2 (and indexed AVA ≤0.6 cm2/m2) | ||
- Normal flow - Low gradient | |||
- Confirmation of internal consistency of the AVA, flow, and gradient measurements - Evidence of a severely calcified valve | |||
- Symptoms believed to be due to AS - Low surgical risk | |||
| bgcolor="LightCoral" | R (3) || bgcolor="LightCoral" | R (3) || bgcolor="LightGreen" | A (7) | |||
|- | |- | ||
| colspan="4" | '''A''' = Appropriate; '''AS''' = aortic stenosis; '''AVA''' = aortic valve area; '''AVR''' = aortic valve replacement; '''BAV''' = balloon aortic valvuloplasty; '''CT''' = computed tomography; '''LVEF''' = left ventricular ejection fraction; '''M''' = May Be Appropriate; '''R''' = Rarely Appropriate; '''SAVR''' = surgical aortic valve replacement; '''TAVR''' = transcatheter aortic valve replacement; '''Vmax''' = peak aortic valve velocity. | | colspan="4" | '''A''' = Appropriate; '''AS''' = aortic stenosis; '''AVA''' = aortic valve area; '''AVR''' = aortic valve replacement; '''BAV''' = balloon aortic valvuloplasty; '''CT''' = computed tomography; '''LVEF''' = left ventricular ejection fraction; '''M''' = May Be Appropriate; '''R''' = Rarely Appropriate; '''SAVR''' = surgical aortic valve replacement; '''TAVR''' = transcatheter aortic valve replacement; '''Vmax''' = peak aortic valve velocity. | ||
|} | |} |
Revision as of 13:28, 1 November 2017
Template:TAVI - AUC
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Associate Editor(s)-in-Chief: Arzu Kalayci, M.D. [2]
ACC/AATS/AHA/ASE/EACTS/ HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis
Asymptomatic, High-Gradient, Severe AS
Appropriate Use Median Score (1–9)
Indication | No Intervention | AVR (TAVR or SAVR) |
---|---|---|
- LVEF ≤50%
- Vmax 4.0–4.9 m/sec - Negative exercise stress test - No predictors of symptom onset or of rapid progression (e.g., DVmax >0.3 m/s/y, severe valve calcification, elevated BNP, or excessive LV hypertrophy in the absence of hypertension) - High or intermediate surgical risk |
A (7) | M (5) |
- LVEF ≤50%
- Vmax 4.0–4.9 m/sec - Negative exercise stress test - No predictors of symptom onset or of rapid progression (e.g., DVmax >0.3 m/s/y, severe valve calcification, elevated BNP, or excessive LV hypertrophy in the absence of hypertension) - Low surgical risk |
A (7) | M (5) |
- LVEF ≥50%
- Vmax 4.0–4.9 m/sec - High-risk profession (e.g., airline pilot) or lifestyle (e.g., competitive athlete) or anticipated prolonged time away from close medical supervision - Low surgical risk |
M (4) | A (7) |
- LVEF ≥50%
- Vmax 4.0–4.9 m/sec - High-risk profession (e.g., airline pilot) or lifestyle (e.g., competitive athlete) or anticipated prolonged time away from close medical supervision - Low surgical risk |
M (4) | A (7) |
- LVEF ≥50%
- Vmax 4.0–4.9 m/sec - Negative exercise stress test - ≥1 predictor(s) of symptom onset or of rapid progression (e.g., DVmax >0.3 m/s/y, severe valve calcification, elevated BNP, or excessive LV hypertrophy in the absence of hypertension) - High or intermediate surgical risk |
M (4) | A (7) |
- LVEF ≥50%
- Vmax 4.0–4.9 m/sec - Negative exercise stress test - ≥1 predictor(s) of symptom onset or of rapid progression (e.g., DVmax >0.3 m/s/y, severe valve calcification, elevated BNP, or excessive LV hypertrophy in the absence of hypertension) - Low surgical risk |
M (4) | A (8) |
- LVEF ≥50% - Vmax 4.0–4.9 m/sec
- Abnormal exercise stress test - High or intermediate surgical risk |
R (3) | A (8) |
- LVEF ≥50%
- Vmax 4.0–4.9 m/sec - Abnormal exercise stress test - Low surgical risk |
R (2) | A (8) |
- LVEF ≥50%
- Very severe AS (Vmax ≥5 m/sec or mean gradient ≥60 mmHg) - High or intermediate surgical risk |
M (4) | A (7) |
- LVEF ≥50%
- Very severe AS (Vmax ≥5 m/sec or mean gradient ≥60 mmHg) - Low surgical risk |
R (2) | A (8) |
- LVEF <50%
- Very severe AS (Vmax ≥4 m/sec or mean gradient ≥40 mmHg) - High or intermediate surgical risk |
R (2) | A (8) |
- LVEF <50%
- Very severe AS (Vmax ≥4 m/sec or mean gradient ≥40 mmHg) - Low surgical risk |
R (1) | A (9) |
- Undergoing another cardiac surgery or ascending aortic surgery | R (1) | A (9) |
A = Appropriate; AS = aortic stenosis; AVR = aortic valve replacement; BNP = b-type natriuretic peptide; LV = left ventricular/left ventricle; LVEF = left ventricular ejection fraction; M = May Be Appropriate; R = Rarely Appropriate; SAVR = surgical aortic valve replacement; TAVR = transcatheter aortic valve replacement; Vmax = peak aortic valve velocity. |
Flow, Gradient and Ejection Fraction
Appropriate Use Median Score (1–9)
Indication | No Intervention | BAV (as Bridge to Decision) | AVR (TAVR or SAVR) |
---|---|---|---|
Reduced Ejection Fraction (<50%) | |||
- AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) on resting echo
- LVEF 20% to 49% - Low flow - Low gradient - Flow reserve on low-dose dobutamine echo - Truly severe AS - High or intermediate surgical risk |
bgcolor="LightCoral" | R (1) | R (3) | A (8) |
- AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) on resting echo
- LVEF 20% to 49% - Low flow - Low gradient - Flow reserve on low-dose dobutamine echo - Truly severe AS - Low surgical risk |
bgcolor="LightCoral" | R (1) | R (2) | A (9) |
- AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) on resting echo
- LVEF 20% to 49% - Low flow - Low gradient - Flow reserve on low-dose dobutamine echo - Pseudosevere AS |
bgcolor="LightGreen" | A (8) | R (2) | R (2) |
- AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) on resting echo
- LVEF 20% to 49% - Low flow - Low gradient - No flow reserve on low-dose dobutamine echo - Very calcified aortic valve on echo and/or CT, suggesting truly severe AS, or calculation of a projected valve area that remains severely reduced - High or intermediate surgical risk |
bgcolor="LemonChiffon" | M (4) | M (5) | A (7) |
- AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) on resting echo
- LVEF 20% to 49% - Low flow - Low gradient - No flow reserve on low-dose dobutamine echo - Minimal calcification on aortic valve on echo and/or CT - High or intermediate surgical risk |
bgcolor="LightGreen" | A (7) | R (3) | R (2) |
- AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2)
- LVEF <20% - Vmax ≥4 m/sec or mean gradient ≥40 mmHg on resting echo - High or intermediate surgical risk |
bgcolor="LightCoral" | R (3) | M (4) | A (7) |
- AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2)
- LVEF <20% - Mean gradient <20 mmHg on resting echo - No flow reserve on low-dose dobutamine echo - High or intermediate surgical risk |
bgcolor="LightGreen" | A (7) | M (4) | R (3) |
- AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) on resting echo
- LVEF <20% - Low flow - Low gradient - Flow reserve on low-dose dobutamine echo - Truly severe AS - High or intermediate surgical risk |
bgcolor="LightCoral" | R (3) | M (5) | A (7) |
- AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2) on resting echo
- LVEF <20% - Low flow - Low gradient - Flow reserve on low-dose dobutamine echo - Pseudosevere severe AS - High or intermediate surgical risk |
bgcolor="LightGreen" | A (7) | R (2) | R (2) |
Preserved Ejection Fraction (≥50%) | |||
- AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2)
- Vmax ≥4 m/sec or mean gradient ≥40 mmHg on resting echo - Symptomatic - High or intermediate surgical risk |
R (1) | R (2) | A (9) |
- AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2)
- Vmax ≥4 m/sec or mean gradient ≥40 mmHg on resting echo - Symptomatic - Low surgical risk |
R (1) | R (1) | A (9) |
- AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2)
- Low flow - Low gradient - Symptomatic - Evidence of a severely calcified valve - Clinical, hemodynamic, and anatomic data support valve obstruction as the most likely cause of symptoms - High or intermediate surgical risk |
R (2) | R (3) | A (8) |
- AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2)
- Low flow - Low gradient - Symptomatic - Evidence of a severely calcified valve - Clinical, hemodynamic, and anatomic data support valve obstruction as the most likely cause of symptoms - Low surgical risk |
R (1) | R (1) | A (9) |
- AVA ≤1.0 cm2 (or indexed AVA ≤0.6 cm2/m2)
- Low flow - Low gradient - Evidence of a severely calcified valve - Asymptomatic - High or intermediate surgical risk |
M (6) | R (3) | M (4) |
- AVA ≤1.0 cm2 (and indexed AVA ≤0.6 cm2/m2)
- Low gradient - Low flow - Evidence of a severely calcified valve - Asymptomatic - Low surgical risk |
M (6) | R (2) | M (4) |
- AVA ≤1.0 cm2 (and indexed AVA ≤0.6 cm2/m2)
- Normal flow - Low gradient - Confirmation of internal consistency of the AVA, flow, and gradient measurements - Evidence of a severely calcified valve - Symptoms believed to be due to AS - High or intermediate surgical risk |
R (3) | M (4) | A (7) |
- AVA ≤1.0 cm2 (and indexed AVA ≤0.6 cm2/m2)
- Normal flow - Low gradient - Confirmation of internal consistency of the AVA, flow, and gradient measurements - Evidence of a severely calcified valve - Symptoms believed to be due to AS - Low surgical risk |
R (3) | R (3) | A (7) |
A = Appropriate; AS = aortic stenosis; AVA = aortic valve area; AVR = aortic valve replacement; BAV = balloon aortic valvuloplasty; CT = computed tomography; LVEF = left ventricular ejection fraction; M = May Be Appropriate; R = Rarely Appropriate; SAVR = surgical aortic valve replacement; TAVR = transcatheter aortic valve replacement; Vmax = peak aortic valve velocity. |